In the noon of November 1, 2018, Dr. Ming-Wei Wang (Dean, School of Pharmacy, Fudan University and Director, The National Center for Drug Screening/The Chinese National Compound Library) met with Dr. Søren Tullin (Corporate Vice President, Discovery Biology & Technology and Head of China R&D Operations) at Terminal 3, Beijing Capital International Airport. They discussed in great detail about the impact and measures to several bilateral and multilateral co-operation projects following a major development strategy shift at Novo Nordisk A/S announced recently. An agreement was reached relative to future communication channels and key areas of collaboration.